CY1123146T1 - Καλλιεργεια κυτταρου θηλαστικου - Google Patents

Καλλιεργεια κυτταρου θηλαστικου

Info

Publication number
CY1123146T1
CY1123146T1 CY20201100473T CY201100473T CY1123146T1 CY 1123146 T1 CY1123146 T1 CY 1123146T1 CY 20201100473 T CY20201100473 T CY 20201100473T CY 201100473 T CY201100473 T CY 201100473T CY 1123146 T1 CY1123146 T1 CY 1123146T1
Authority
CY
Cyprus
Prior art keywords
cell culture
mammalian cell
provides
mammalian cells
control over
Prior art date
Application number
CY20201100473T
Other languages
English (en)
Inventor
Brian D. Follstad
Rebecca E. Mccoy
Arvia E. Morris
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46579326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123146(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of CY1123146T1 publication Critical patent/CY1123146T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Abstract

Η εφεύρεση παρέχει μια μέθοδο για την καλλιέργεια κυττάρων θηλαστικού. Η μέθοδος παρέχει μεγαλύτερο έλεγχο επί της ανάπτυξης κυττάρου για να επιτυγχάνεται υψηλός τίτλος προϊόντος κυτταρικών καλλιεργειών.
CY20201100473T 2011-07-01 2020-05-25 Καλλιεργεια κυτταρου θηλαστικου CY1123146T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161503737P 2011-07-01 2011-07-01
EP12738674.6A EP2726600B1 (en) 2011-07-01 2012-06-29 Mammalian cell culture
PCT/US2012/045070 WO2013006479A2 (en) 2011-07-01 2012-06-29 Mammalian cell culture

Publications (1)

Publication Number Publication Date
CY1123146T1 true CY1123146T1 (el) 2021-12-31

Family

ID=46579326

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20171100366T CY1118863T1 (el) 2011-07-01 2017-03-22 Καλλιεργεια κυτταρου θηλαστικου
CY20201100473T CY1123146T1 (el) 2011-07-01 2020-05-25 Καλλιεργεια κυτταρου θηλαστικου

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20171100366T CY1118863T1 (el) 2011-07-01 2017-03-22 Καλλιεργεια κυτταρου θηλαστικου

Country Status (24)

Country Link
US (7) US11292829B2 (el)
EP (2) EP2837680B1 (el)
JP (1) JP5897708B2 (el)
KR (7) KR101662412B1 (el)
CN (2) CN107988166B (el)
AU (5) AU2012279230B2 (el)
BR (2) BR122021007265B1 (el)
CA (2) CA2838695C (el)
CL (2) CL2013003792A1 (el)
CY (2) CY1118863T1 (el)
DK (2) DK2726600T3 (el)
EA (1) EA039023B1 (el)
ES (2) ES2788132T3 (el)
HK (2) HK1197081A1 (el)
HU (2) HUE049119T2 (el)
IL (5) IL297998B1 (el)
LT (2) LT2726600T (el)
MX (1) MX351974B (el)
PL (2) PL2837680T3 (el)
PT (2) PT2726600T (el)
SG (1) SG10201702537RA (el)
SI (2) SI2837680T1 (el)
WO (1) WO2013006479A2 (el)
ZA (1) ZA201309372B (el)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201708537A (zh) 2006-09-13 2017-03-01 艾伯維有限公司 細胞培養改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
AU2009347206C1 (en) 2008-10-20 2016-12-08 Abbvie Inc. Isolation and purification of antibodies using Protein A affinity chromatography
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN107988166B (zh) * 2011-07-01 2022-03-15 美国安进公司 哺乳动物细胞培养
US10485869B2 (en) 2011-10-18 2019-11-26 Coherus Biosciences, Inc. Etanercept formulations stabilized with meglumine
WO2013059407A1 (en) 2011-10-18 2013-04-25 Coherus Biosciences, Inc. Etanercept formulations stabilized with sodium chloride
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
EP2869816A4 (en) 2012-07-09 2016-04-20 Coherus Biosciences Inc FORMANTS OF ETANERCEPT HAVING A REDUCTION MARKED IN INVISIBLE PARTICLES IN THE NU
SG11201504249XA (en) 2012-09-02 2015-07-30 Abbvie Inc Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CN110051823A (zh) 2012-09-11 2019-07-26 科荣生生物科学公司 高纯度和优异产量的正确折叠的依那西普
US20150353542A1 (en) * 2013-01-14 2015-12-10 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
TWI720289B (zh) 2013-03-14 2021-03-01 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
WO2014160790A1 (en) 2013-03-26 2014-10-02 Coherus Biosciences, Inc. Protein production method
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
CA2929077A1 (en) * 2013-10-31 2015-05-07 Amgen Inc. Use of monensin to regulate glycosylation of recombinant proteins
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2015095809A1 (en) 2013-12-20 2015-06-25 Biogen Idec Ma Inc. Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
SG11201605640UA (en) 2014-01-13 2016-08-30 Amgen Inc Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins
MX362923B (es) 2014-01-30 2019-02-25 Coherus Biosciences Inc Medios de perfusión.
IL249150B (en) 2014-06-04 2022-09-01 Amgen Inc Methods for collecting mammalian cell cultures
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) * 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法（ｓｅｅｄ ｔｒａｉｎ ｐｒｏｃｅｓｓｅｓ）及其用途
JP6530171B2 (ja) * 2014-09-09 2019-06-12 旭化成メディカル株式会社 培養産生物の回収方法
SG10202002458PA (en) * 2014-12-01 2020-04-29 Amgen Inc Process for manipulating the level of glycan content of a glycoprotein
KR102007930B1 (ko) 2014-12-31 2019-08-06 주식회사 엘지화학 재조합 당단백질의 글리코실화 조절 방법
CN105385731B (zh) * 2015-12-25 2018-10-30 上海莱士血液制品股份有限公司 一种表达重组八因子的灌注培养方法
CN109153717A (zh) * 2016-01-06 2019-01-04 安口生物公司 减少单克隆抗体组合物中的高分子量物类、酸性电荷物类和片段
AU2017213775A1 (en) 2016-02-03 2018-08-16 Outlook Therapeutics, Inc. Buffer formulations for enhanced antibody stability
US11377677B2 (en) 2016-03-02 2022-07-05 Lonza Ltd Fermentation process
CA3054593A1 (en) * 2017-03-31 2018-10-04 Boehringer Ingelheim International Gmbh Perfusion medium
KR102604992B1 (ko) * 2017-03-31 2023-11-24 베링거 인겔하임 인터내셔날 게엠베하 관류 배지
US11851678B2 (en) 2017-08-09 2023-12-26 Juno Therapeutics, Inc. Methods for producing genetically engineered cell compositions and related compositions
CN111344558A (zh) 2017-10-06 2020-06-26 龙沙有限公司 使用拉曼光谱法自动控制细胞培养
EP4039786A1 (en) 2017-10-16 2022-08-10 Regeneron Pharmaceuticals, Inc. Perfusion bioreactor and related methods of use
CA3084445A1 (en) * 2017-12-08 2019-06-13 Juno Therapeutics, Inc. Process for producing a composition of engineered t cells
AU2019419406B2 (en) * 2018-12-31 2023-05-18 Repligen Corporation Filter for mammalian cell culture perfusion and clarification with hydrophobic hollow fiber
US20230313259A1 (en) * 2020-08-14 2023-10-05 Bristol-Myers Squibb Company Manufacturing process for protein
KR20230058094A (ko) * 2020-08-31 2023-05-02 리제너론 파아마슈티컬스, 인크. 세포 배양 성능을 개선하고 아스파라긴 서열 변이체를 완화하기 위한 아스파라긴 공급 전략
CN114574430A (zh) * 2022-03-22 2022-06-03 成都博宠生物科技有限公司 一种Expi293F细胞培养方法
CN115287251A (zh) * 2022-08-25 2022-11-04 无锡药明生物技术股份有限公司 间歇性灌流联合分批流加培养
WO2024054414A1 (en) 2022-09-06 2024-03-14 Amgen Inc. Lean perfusion cell culture methods
WO2024059235A2 (en) 2022-09-16 2024-03-21 Amgen Inc. A method for harvesting products from perfusion cultures
CN116790483B (zh) * 2023-08-22 2023-10-20 苏州依科赛生物科技股份有限公司 一种cho细胞无血清培养基及其应用

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4499064A (en) 1982-06-03 1985-02-12 Clayton Foundation For Research Assessment of nutritional status of individuals
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US4816401A (en) * 1985-09-09 1989-03-28 University Of Rochester Serum free cell culture medium
US5045468A (en) * 1986-12-12 1991-09-03 Cell Enterprises, Inc. Protein-free culture medium which promotes hybridoma growth
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE10399023I2 (de) 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US7037721B1 (en) * 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5292655A (en) * 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
WO1994010308A1 (en) 1992-10-23 1994-05-11 Immunex Corporation Methods of preparing soluble, oligomeric proteins
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6310185B1 (en) 1994-03-08 2001-10-30 Memorial Sloan Kettering Cancer Center Recombinant human anti-Lewis Y antibodies
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
DK1666591T3 (da) 1995-06-29 2011-05-23 Immunex Corp Cytokin der inducerer apoptose
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
WO1998008934A1 (en) 1996-08-30 1998-03-05 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US20030036505A1 (en) 2000-09-25 2003-02-20 Human Genome Sciences, Inc. Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon
WO2002101019A2 (en) 2001-06-13 2002-12-19 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
AU2003220529B2 (en) 2002-03-27 2006-09-07 Immunex Corporation Methods for increasing polypeptide production
PT1720972E (pt) * 2004-03-05 2014-04-07 Dsm Ip Assets Bv Processo para cultura de células por perfusão contínua e fluxo alternativo tangencial
CN1332024C (zh) * 2004-06-09 2007-08-15 中国科学院大连化学物理研究所 一种海绵细胞的微载体三维培养方法
ATE505219T1 (de) 2004-07-07 2011-04-15 Coloplast As Katheter enthaltend estane 58212
TWI374935B (en) * 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
US7294484B2 (en) * 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
US7598083B2 (en) * 2004-10-29 2009-10-06 Centocor, Inc. Chemically defined media compositions
JP5199073B2 (ja) 2005-06-03 2013-05-15 アレス トレーディング ソシエテ アノニム 組換えｉｌ−１８結合タンパク質の生産
CN104263700A (zh) 2006-07-14 2015-01-07 帝斯曼知识产权资产管理有限公司 改进的细胞培养方法
WO2008024769A2 (en) * 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
CN101535469A (zh) 2006-11-08 2009-09-16 惠氏公司 合理设计的细胞培养基
WO2008154014A2 (en) 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
US20090042253A1 (en) 2007-08-09 2009-02-12 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
MX347112B (es) 2008-09-15 2017-04-12 Genentech Inc Composiciones y metodos para regular osmolaridad celular.
CN101603026B (zh) * 2009-06-19 2011-01-19 华东理工大学 适于动物细胞产品生产的无动物来源低蛋白培养基
CN102549145B (zh) 2009-07-31 2015-05-20 巴克斯特国际公司 用于adamts蛋白表达的细胞培养基
US8580554B2 (en) 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture
RU2639288C2 (ru) 2009-08-11 2017-12-20 Дженентек, Инк. Получение белков в культуральных средах без глутамина
RS56484B1 (sr) 2009-11-17 2018-01-31 Squibb & Sons Llc Metode za poboljšanu proizvodnju proteina
WO2011065940A1 (en) 2009-11-24 2011-06-03 Biogen Idec Ma Inc. Method of supplementing culture media to prevent undesirable amino acid substitutions
AU2011324870B2 (en) * 2010-11-01 2015-01-29 Symphogen A/S pan-HER antibody composition
US9133493B2 (en) * 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
CN107988166B (zh) * 2011-07-01 2022-03-15 美国安进公司 哺乳动物细胞培养
TWI720289B (zh) 2013-03-14 2021-03-01 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
CA2929077A1 (en) 2013-10-31 2015-05-07 Amgen Inc. Use of monensin to regulate glycosylation of recombinant proteins
AU2016357567B2 (en) * 2015-11-17 2020-05-07 Pfizer Inc. Media and fermentation methods for producing polysaccharides in bacterial cell culture

Also Published As

Publication number Publication date
JP5897708B2 (ja) 2016-03-30
KR101662412B1 (ko) 2016-10-04
AU2018203972A1 (en) 2018-06-21
WO2013006479A3 (en) 2013-03-28
KR101857380B1 (ko) 2018-05-11
SI2837680T1 (sl) 2020-07-31
JP2014520534A (ja) 2014-08-25
PL2726600T3 (pl) 2017-08-31
HUE049119T2 (hu) 2020-09-28
CL2016001190A1 (es) 2017-06-09
SI2726600T1 (sl) 2017-07-31
KR20240005106A (ko) 2024-01-11
US20200407427A1 (en) 2020-12-31
KR20160075814A (ko) 2016-06-29
EA201391826A1 (ru) 2014-04-30
LT2837680T (lt) 2020-07-10
US20220185869A1 (en) 2022-06-16
EA039023B1 (ru) 2021-11-23
IL278430B (en) 2022-01-01
US11673941B2 (en) 2023-06-13
KR20230114317A (ko) 2023-08-01
DK2837680T3 (da) 2020-04-27
IL297998B1 (en) 2024-03-01
CN107988166B (zh) 2022-03-15
WO2013006479A2 (en) 2013-01-10
CN107988166A (zh) 2018-05-04
CN103827292B (zh) 2018-01-26
CA2838695A1 (en) 2013-01-10
CY1118863T1 (el) 2018-01-10
KR20140031375A (ko) 2014-03-12
CL2013003792A1 (es) 2014-07-25
US20140255993A1 (en) 2014-09-11
CA2952347A1 (en) 2013-01-10
AU2012279230B2 (en) 2016-08-18
IL229803B (en) 2020-11-30
BR112013033730B1 (pt) 2022-01-25
HK1206057A1 (en) 2015-12-31
EP2837680B1 (en) 2020-02-26
EP2726600A2 (en) 2014-05-07
DK2726600T3 (en) 2017-05-15
LT2726600T (lt) 2017-05-25
MX2013014937A (es) 2014-04-16
US20230117598A1 (en) 2023-04-20
EP2837680A1 (en) 2015-02-18
US11292829B2 (en) 2022-04-05
AU2016244255A1 (en) 2016-10-27
KR102558247B1 (ko) 2023-07-24
PT2837680T (pt) 2020-04-17
SG10201702537RA (en) 2017-04-27
BR122021007265B1 (pt) 2022-02-22
US11685772B2 (en) 2023-06-27
PL2837680T3 (pl) 2020-08-10
IL288509B2 (en) 2023-04-01
ES2625045T3 (es) 2017-07-18
MX351974B (es) 2017-11-06
US11827692B2 (en) 2023-11-28
AU2012279230A1 (en) 2014-01-09
KR20180050433A (ko) 2018-05-14
PT2726600T (pt) 2017-04-24
US20210061888A1 (en) 2021-03-04
KR102108663B1 (ko) 2020-05-07
KR20200051046A (ko) 2020-05-12
US11634476B2 (en) 2023-04-25
AU2020281075B2 (en) 2022-12-22
IL297998A (en) 2023-01-01
US20230227535A1 (en) 2023-07-20
ZA201309372B (en) 2014-08-27
US20230129523A1 (en) 2023-04-27
AU2018203972B2 (en) 2020-09-17
IL310968A (en) 2024-04-01
ES2788132T3 (es) 2020-10-20
KR20220021008A (ko) 2022-02-21
AU2023201127A1 (en) 2023-03-30
AU2020281075A1 (en) 2021-01-07
IL288509A (en) 2022-01-01
CA2838695C (en) 2017-02-14
HK1197081A1 (en) 2015-01-02
CN103827292A (zh) 2014-05-28
BR112013033730A2 (pt) 2017-01-31
KR102358951B1 (ko) 2022-02-08
EP2726600B1 (en) 2017-02-15
HUE033279T2 (en) 2017-11-28
IL288509B (en) 2022-12-01

Similar Documents

Publication Publication Date Title
CY1123146T1 (el) Καλλιεργεια κυτταρου θηλαστικου
BRPI1008219A2 (pt) Biorreator para o cultivo de células de mamíferos
EP2982742A4 (en) PHOTOBIOREACTOR FOR THE MASS CULTIVATION OF PHOTOSYNTHESEMICROORGANISM
SG10201811616SA (en) Cell culture media
EP2729561A4 (en) CELL CULTURE METHOD
EP2674025A4 (en) CULTURE MEDIUM FOR PLANT CULTURE
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
EP3030647A4 (en) Methods of producing algal cell cultures and biomass, lipid compounds and compositions, and related products
EP2843041A4 (en) CULTURE MEDIUM FOR STEM CELLS AND METHOD FOR CULTIVATING STEM CELLS USING THE SAME
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
EP3162892A4 (en) Method for culturing adhesive cells, culture vessel, and method for producing protein
GB2482612B (en) Cell culture support for culturing mesenchymal stem cells
IN2014DN09097A (el)
EA200900984A1 (ru) Улучшение клеточного роста
EP3069591A4 (en) Bioreactor for in vitro plant culture
SG10201808061WA (en) Method for the clarification of high density crude cell culture harvest
EP2695934A4 (en) CULTURE KIT FOR ANIMAL CELLS, METHOD FOR LIVING ANIMAL CELLS, METHOD FOR SELECTIVATING LIVESTOCK CELLS AND CELL DIFFERENTIATION METHOD
FR2940315B1 (fr) Nouveau procede de culture de levures du genre yarrowia
GB202011948D0 (en) Bioreactor for cell culture
FR2957355B1 (fr) Procede de culture de cellules adherentes a des microporteurs
GB201007863D0 (en) Bioreactor for cell culture
GB201105503D0 (en) Microcarrier for the culture if stem cells, method of culturing stem cells and method of using said microcarrier
GB201007861D0 (en) Dynamic bioreactor for cell culture